ARCHIVES

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996

In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations

May 28, 1993

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992